Type I Interferon as a Target of Treatment in SLE

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|6|4|323-330

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.4, 2006-12, pp. : 323-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary Sjogren's Syndrome and the Type I Interferon System

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. : 2054-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon as a target for the treatment of Type 2 diabetes

By Sloop Kyle W   Michael M Dodson   Moyers Julie S  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

VITAMIN C ATTENUATION OF THE DEVELOPMENT OF TYPE I DIABETES MELLITUS BY INTERFERON-

By Al-Zuhair H.   Mohamed H.E.  

Pharmacological Research, Vol. 38, Iss. 1, 1998-07 ,pp. : 59-64

Academic Press

Access to resources Recommend Favorite

Research Highlights: Clinical relevance of the type I interferon signature in multiple sclerosis

By Verweij Cornelis L  

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1883-1885

Future Medicine

Access to resources Recommend Favorite

Viral targeting of interferon regulatory factor-3 and type I interferon gene transcription

By Fitzgerald Katherine A  

Future Virology, Vol. 1, Iss. 6, 2006-11 ,pp. : 783-793

Future Medicine

Access to resources Recommend Favorite